Eqalix, Inc CEO to Present at the BIO Investor Forum in San Francisco, October 9 – 10, 2012
Eqalix, Inc, an emerging biotechnology company in the Regenerative Medicine space, developing nanotechnologies to replicate the function of damaged, diseased or aging tissues by providing implants that are non-immunogenic and bio-compatible is scheduled to present at the 11th annual BIO Investor... - October 05, 2012
Eqalix, Inc, CEO to Present at the 2012 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum
Joseph P. Connell, Eqalix, Inc CEO will be presenting at the 2012 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum - the regenerative medicine industry’s premier business development and partnering meeting. The Investor and Partnering Forum is being organized by the Alliance for Regenerative Medicine (ARM) and the California Institute for Regenerative Medicine to profile the industry’s most exciting technologies. - October 02, 2012